Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Uncovering key targets of success for immunotherapy in pancreatic cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 13, 2021 Category: Drugs & Pharmacology Authors: Andrea Pretta Eleonora Lai Mara Persano Clelia Donisi Giovanna Pinna Erika Cimbro Alissa Parrino Dario Spanu Stefano Mariani Nicole Liscia Marco Dubois Marco Migliari Valentino Impera Giorgio Saba Valeria Pusceddu Marco Puzzoni Pina Ziranu Mario Scartozzi Source Type: research

Alternative antigen to defuse SARS-CoV-2 delta variant and its ensuing evolutionary lineage
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 7, 2021 Category: Drugs & Pharmacology Authors: Ariel Fern ández Stigliano Source Type: research

Retinal vein occlusion: drug targets and therapeutic implications
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 7, 2021 Category: Drugs & Pharmacology Authors: Alessandro Arrigo Francesco Bandello Source Type: research

Epigenetic regulatory mechanisms of histone acetylation in the treatment of cutaneous squamous cell carcinoma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 3, 2021 Category: Drugs & Pharmacology Authors: Tejas P. Joshi Morgan A. Farr Daniel J. Lewis Source Type: research

Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 3, 2021 Category: Drugs & Pharmacology Authors: Juan Wang Emilien Loeuillard Gregory J. Gores Sumera I. Ilyas Source Type: research

Clostridioides difficile: innovations in target discovery and potential for therapeutic success
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 2, 2021 Category: Drugs & Pharmacology Authors: Tanya M Monaghan Anna M Seekatz Benjamin H Mullish Claudia C. E. R Moore-Gillon Lisa F. Dawson Ammar Ahmed Dina Kao Weng C Chan Source Type: research

Correspondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 29, 2021 Category: Drugs & Pharmacology Authors: Dhriti Kaushik Ranjana Bhandari Anurag Kuhad Source Type: research

Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 26, 2021 Category: Drugs & Pharmacology Authors: Sunghark Kwon So Yeong Cheon Source Type: research

Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson ’s disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 26, 2021 Category: Drugs & Pharmacology Authors: Fanni Annam ária Boros L ászló Vécsei Source Type: research

Novel immune targets for the treatment of triple-negative breast cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 25, 2021 Category: Drugs & Pharmacology Authors: Chiara Corti Eleonora Nicol ò Giuseppe Curigliano Source Type: research

NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 18, 2021 Category: Drugs & Pharmacology Authors: Domenico Trombetta Angelo Sparaneo Federico Pio Fabrizio Concetta Martina Di Micco Antonio Rossi Lucia Anna Muscarella Source Type: research

Role of hemagglutinin esterase in replication of SARS-CoV-2
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 18, 2021 Category: Drugs & Pharmacology Authors: Milad Zandi Saber Soltani Parastoo Hosseini Source Type: research

A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 18, 2021 Category: Drugs & Pharmacology Authors: Stuart K Roberts Ammar Majeed Source Type: research

New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD)
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 2, 2021 Category: Drugs & Pharmacology Authors: Hannah Choe James L.M. Ferrara Source Type: research

Taking the road less traveled – the therapeutic potential of CBP/β-catenin antagonists
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 27, 2021 Category: Drugs & Pharmacology Authors: Michael Kahn Source Type: research